Monthly Archives: January 2009

Audio Journal of Fertility

johan smitz Audio Journal of Fertility
Johan Smitz

In Manchester, Peter Goodwin hears from MASTERCLASS chair Masoud Afnan, guest experts Johan Smitz and Richard Fleming and participant Gedis Grudzinskas about the evidence base underscoring new recommendations for treating infertility, and at the ESHRE meeting in Barcelona from Maria Lalioti and Richard Anderson about follicle stimulating hormone “splice variants” and ovarian hyperstimulation, and from Anja Pinborg on the superiority of cryo-preservation for single embryo transfer.

SPEAKERS:
Johan Smitz, Free University of Brussels
Richard Fleming, Glasgow University
Masoud Afnan, Birmingham Women’s Hospital
Gedis Grudzinskas, Bridge Centre, London
Maria Lalioti, Yale University, New Haven CT
Richard Anderson, University of Edinburgh
Anja Pinborg, Rigshospitalet, Copenhagen, Denmark

richard fleming Audio Journal of Fertility
Richard Fleming

masoud afnan Audio Journal of Fertility
Masoud Afnan

maria lalioti Audio Journal of Fertility
Maria Lalioti

anja pinborg Audio Journal of Fertility
Anja Pinborg

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

Posted in Fertility | Tagged , , , , , , | Leave a comment

Oncology Times Broadcast News with the Audio Journal of Oncology

francseco zaja Oncology Times Broadcast News with the Audio Journal of Oncology
Francesco Zaja

The exciting recent ASH conference reflected the vibrant mood of an America boldly tackling economic and political turmoil with post-presidential-election optimism. Peter Goodwin and George Canellos reflect on some of the big stories and talk with key investigators in San Francisco. Francesco Zaja recounts how rituximab has proved effective for treating immune thrombocytopenic purpura (ITP); Hannes Wandt presents compelling data suggesting that platelet transfusions can be withheld in many patients receiving stem cell transplants for their hematologic malignancies; and both Michael Hallek and Tadeusz Robak announce Phase III study findings of improved benefits for patients whose chronic lymphocytic leukemia has been treated by adding rituximab to standard chemotherapy. The ASH President, Kenneth Kaushansky, plus Linda Burns and George Canellos contribute their comments to put the new findings into clinical perspective for the busy oncologist.

ken kaushansky Oncology Times Broadcast News with the Audio Journal of Oncology
Kenneth Kaushansky

george canellos Oncology Times Broadcast News with the Audio Journal of Oncology
George Canellos

hannes wandt Oncology Times Broadcast News with the Audio Journal of Oncology
Hannes Wandt

linda burns Oncology Times Broadcast News with the Audio Journal of Oncology
Linda Burns

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

Posted in Oncology | Tagged , , , | Leave a comment